miR-302 mimics (Prolifagen)

N/A

Report date: 2025/03/20 14:49:38

NME

Base Information

Drug NamemiR-302 mimics (Prolifagen)

Drug Alias NameN/A

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisenseSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > microRNA

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsHeart Failure

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesProlifagen LLC

China Registration ClassN/A

Develop Information

Active CompaniesProlifagen LLC

Inactive CompaniesN/A

Active IndicationsHeart Failure

Inactive IndicationsN/A

Other Information

ATC CodeN/A